Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
Bio-Rad Diabetes Division

Gene Predicts Prognosis of Breast Cancer Patients Treatment Response

By Labmedica International staff writers
Posted on 08 May 2014
Image: The Novolink Detection kit (Photo courtesy of Leica Microsystems).
Image: The Novolink Detection kit (Photo courtesy of Leica Microsystems).
A gene has been identified which, when expressed in breast cancer, can help to predict a patient's chance of recovery and their likely response to chemotherapy.

As recurrence still occurs in over 20% of patients with breast cancer, it is becoming increasingly important to identify biomarkers that can aid in assessing a patient’s risk and response to therapy and which might also act as novel targets for immunotherapies.

Scientists at Nottingham Trent University (Nottingham, UK) studied the biological, prognostic and predictive values of the helicase antigen (HAGE) expression in a total of 2,147 women in three well characterized cohorts of patients with breast cancer. The relationship between HAGE expression and the tumor-infiltrating lymphocytes (TILs) in matched pre-chemotherapy and post-chemotherapy samples was investigated.

The investigators used tissue microarrays (TMAs) and immunohistochemistry (IHC) to study the surgical specimens obtained from the patients. IHC staining was performed using a Novolink Detection kit (Leica Microsystems, Wetzlar, Germany). To validate the use of TMAs for immunophenotyping, full-face sections of 40 cases were stained, and the protein expression levels were compared.

The team found that 8% of the women with early primary breast cancer exhibited high HAGE expression (HAGE+) and was associated with aggressive clinicopathological features. Women with breast cancer who were considered to be at low risk, but had a high expression of HAGE, were twice as likely to die, or suffer a relapse, than those with “HAGE negative” tumors. The presence of HAGE also appears to limit the effectiveness of hormone therapy, as high risk patients with HAGE negative breast cancer lived for longer with such therapy.

The study revealed that HAGE can predict a patient's response to chemotherapy, as the incidence of relapse in patients with “HAGE positive” breast cancer following chemotherapy was lower than that in patients whose cancer did not express HAGE. Stephanie McArdle, PhD, a senior research fellow and an author of the study, said, “HAGE is implicated in the progression of breast cancer by driving cell growth, and is associated with higher grade tumors and poorer clinical outcome. This is the first report to show that this molecule is a potential prognostic marker and a predictor of a patient's response to hormone therapy and chemotherapy.” The study was published on April 22, 2014, in the British Journal of Cancer.

Related Links:

Nottingham Trent University
Leica Microsystems 



77 ELEKTRONIKA
KARL HECHT GMBH & CO KG
DIASYS DIAGNOSTIC SYSTEMS

Channels

Hematology

view channel
Image: The ADVIA 2120 Hematology System (Photo courtesy of Siemens).

Preoperative Blood Cell Ratios Predict Endometrial Cancer Survival

The variations in systemic inflammatory response biomarker levels have been associated with adverse clinical outcome in various malignancies and the host response to malignant tumors is characterized by... Read more

Immunology

view channel
Image: The Covaris S2 Ultrasonicator for shearing DNA (Photo courtesy of Covaris).

Genetic Mutation Impairs Immunity in Candidiasis and Mycobacteriosis

Human inborn errors of immunity mediated by the cytokines interleukin-17A/F (IL-17A/F) underlie mucocutaneous candidiasis, whereas inborn errors of interferon-γ (IFN-γ) immunity underlie mycobacterial disease.... Read more

Microbiology

view channel
Image: Transmission electron micrograph (TEM) of norovirus virions, or virus particles (Photo courtesy of Charles D. Humphrey/CDC).

Immunochromatography Tests Evaluated for Detection of Novel Norovirus

A novel GII.17 Norovirus has emerged as a major cause of epidemic and endemic acute gastroenteritis in several countries in Asia. From September 2014 to March 2015, 70% of all outbreaks in Guangdong... Read more

Lab Tech.

view channel
Image: Verigene System instrumentation consists of a Verigene Reader and one or multiple Verigene Processor SPs (Photo courtesy of Nanosphere).

Directed Molecular Diagnostic Tests Highlight Recent Microbiology Conference

The performance of a series of directed molecular diagnostic tests was confirmed by several studies presented at a recent microbiology conference. Nanosphere (Northbrook, IL, USA) manufactures tests... Read more

Industry News

view channel

Cancer Genetics Expands Access to Proprietary Diagnostics Through Agreement with Harvard Pilgrim

Under the terms of a new agreement between Cancer Genetics, Inc. (CGI; Morrisville, NC, USA) and Harvard Pilgrim Healthcare (Hartford, CT; USA), a health care network covering over one million people throughout Massachusetts, Connecticut, and Maine, CGI will offer its cancer diagnostic services to individuals covered under... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.